Expert Opinion on Biological Therapy (1471-2598; 1744-7682) is a MEDLINE-indexed, international journal publishing peer-reviewed research across all aspects of biological therapy.
Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.
The audience consists of scientists and managers in the healthcare and biopharmaceutical industries and others closely involved in the development and application of biological therapies for the treatment of human disease.
The journal welcomes:
Reviews covering therapeutic antibodies and vaccines, peptides and proteins, gene therapies and gene transfer technologies, cell-based therapies and regenerative medicine
Drug evaluations reviewing the clinical data on a particular biological agent
Original research papers reporting the results of clinical investigations on biological agents and biotherapeutic-based studies with a strong link to clinical practice
Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:
Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results;
Article Highlights – an executive summary of the author’s most critical points.
《Expert Opinion On Biological Therapy》是一本由TAYLOR & FRANCIS LTD出版商出版的专业医学期刊,该刊创刊于2001年,刊期Bimonthly,该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中,该刊分区信息为大类学科:医学 3区,小类学科:生物工程与应用微生物 3区;医学:研究与实验 3区;在JCR(Journal Citation Reports)分区等级为Q1。该刊发文范围涵盖生物工程与应用微生物等领域,旨在及时、准确、全面地报道国内外生物工程与应用微生物工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等,促进学术交流,鼓励学术创新。2021年影响因子为5.589,平均审稿速度一般,3-8周。
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 3区 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 | 3区 3区 | 否 | 是 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q1 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | Q1 | 5.589 |
MEDICINE, RESEARCH & EXPERIMENTAL | Q2 |
影响因子 | h-index | Gold OA文章占比 | 研究类文章占比 | OA开放访问 | 平均审稿速度 |
5.589 | 75 | 9.98% | 44.09% | 未开放 | 一般,3-8周 |